Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36) [Phase 3]
Phase 3 long-term extension study of aclidinium bromide in chronic obstructive pulmonary disease evaluated safety, tolerability, and efficac…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33) [Phase 3]
Phase 3 study LAS-MD-33 assessed the efficacy and safety of aclidinium bromide in adults with moderate to severe COPD; the study status is c…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35) [Phase 3]
This document reports long-term safety, tolerability, and efficacy results from a Phase 3 study of aclidinium bromide in patients with moder…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Phase 2 trial results evaluate the efficacy of aclidinium bromide in chronic obstructive pulmonary disease (COPD); the study is completed an…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 2]
A Phase 2 trial evaluated three doses of aclidinium bromide in chronic obstructive pulmonary disease and reported efficacy and safety result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: PT005 MDI Dose Ranging Versus Foradil Aerolizer Study [Phase 2]
Phase 2 dose-ranging study comparing PT005 MDI to Foradil Aerolizer in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: The Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung [NA]
Clinical trial update on using endobronchial valves to perform bronchoscopic lung volume reduction in patients with single-lung transplantat…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacodynamic effects of PUR118 in chronic obstructive pulmonary disease has been…
-
FDA approval · 2012-09-06FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) from GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Pressure Dependent Tracheal Obstruction in Copd Patients
This update notes that a clinical trial examining pressure-dependent tracheal obstruction in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A completed clinical trial examining mitochondrial dysfunction and oxidative stress in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS research · 2012-09-03Clinical Trial Update: Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler [EARLY_Phase 1]
Early-phase trial evaluating an oxygen-enhanced MRI method in COPD patients over 8 weeks while treated with Symbicort Turbuhaler or Oxis Tur…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD [Phase 4]
Phase 4 trial evaluating whether Symbicort (budesonide/formoterol) improves exercise tolerance in patients with severe chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide® [Phase 4]
Phase 4 trial evaluating the onset of effect of Symbicort versus Seretide in patients with severe chronic obstructive pulmonary disease.
-
FDA approval · 2012-08-29FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuti…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations
Clinical trial update describing the completed study on inflammatory pathways associated with COPD exacerbations.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease
This clinical trial update reports the completion of a study investigating the effects of inert dust exposure on pathology in patients with …
-
CLINICAL_TRIALS withdrawal · 2012-08-23Clinical Trial Update: Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension [Phase 4]
This Phase 4 trial evaluating sildenafil for COPD-associated pulmonary hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Acupuncture Combined With Pulmonary Rehabilitation: Are There Additional Benefits? [NA]
This ClinicalTrials.gov update reports on a completed study examining whether adding acupuncture to pulmonary rehabilitation provides additi…
-
FDA approval · 2012-08-13FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for the combination inhaler ipratropium bromide and albuterol sulfate from Nephron Pharmaceuticals C…
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)
A Brigham and Women's Hospital trial examining the role of vitamin D in asthma and chronic obstructive pulmonary disease has completed. The …
-
FDA approval · 2012-08-09FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-08-09FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC to…
-
FDA label_change · 2012-08-09FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) from GlaxoSmithKline LLC, resulting in changes to the pro…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients [Phase 4]
Phase 4 trial comparing high-dose versus medium-dose fluticasone in combination with salmeterol for chronic obstructive pulmonary disease to…